Please login to the form below
biopharma
This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.
FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
It gives people more storage options, and more accessibility in locations that today may not be ordering the Pfizer vaccine,” Tanya Alcorn, vice president of Pfizer’s BioPharma Global Supply Chain
Latest news
-
Sanofi gains access to antibody tech with Kymab acquisition
Prior to that, Sanofi signed a huge $3.7bn deal for US-based Principia Biopharma, gaining access to the biotech’s portfolio of Bruton tyrosine kinase (BTK) inhibitors for the treatment
-
Building a brighter future for rare disease patients
With cutting-edge science taking centre stage in orphan drug development, academic institutions and virtual biopharma play a central role in innovation.
-
Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
drugs. One bright spot was an increase in revenues for Pfizer’s biopharma business, which climbed 4% to $10.2bn in the third quarter.
-
Biopharma industry encouraged by EMA’s COVID-19 transparency measures
IFPMA and EFPIA welcome new transparency measures for potential treatments and vaccines
-
Researchers call on Pfizer to delay COVID-19 vaccine application
In the pledge, the biopharma leaders promised to 'only submit (a vaccine) for approval or emergency use authorisation after demonstrating safety and efficacy through a phase 3 clinical study that is
More from news
Approximately 20 fully matching, plus 445 partially matching documents found.
Latest Intelligence
-
Integrating competitive intelligence into business development, licensing and M&A strategy
One of the most profitable areas for biopharma companies to see the greatest return on their competitive intelligence (CI) investment is through its application to business development and licensing (BD&L) ... In an ever- increasing world of
-
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
This ‘speed chess’ approach could be a winning strategy for emerging biopharma companies (EBCs). ... Emerging biopharma comes of age: advantages, but also liabilities. According to an IQVIA Clinical Development Trends Impact Assessment, EBCs account
-
The impact of COVID-19 on clinical trials
loss). Biopharma companies seem to be primarily focused on pausing or delaying trials that are in patient recruitment or planning stages.
-
AI and genomics: a revolution in drug discovery and development
The omics approach could also help biotech companies attract acquisitive biopharma companies.
-
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic.
More from intelligence
Approximately 1 fully matching, plus 85 partially matching documents found.
Latest appointments
-
New hires at Crescendo, Healx and Galecto
Prior to joining Healx, he worked as CMO at Aparito and as therapeutic area head of orphan drugs at Mereo BioPharma.
-
New hires at FibroGen, Saniona and Turbine
Jenkins is a biopharma thought leader with over 25 years of industry experience, whose leadership roles have included global head of R&D at Merck Serono, and several senior positions at
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
While at Ipsen, Meek led a growth strategy of financial results and pipeline advancement and transformed the company into a global biopharma leader.
-
New faces at Healthware Group and HRW
ups, biopharma companies, technology firms and others. She will be based in New York City, US.
-
Health comms agency emotive hires new cell and gene therapy leader
An expert in cell and gene therapies, Dr Ferrari joins emotive following 20 years in research as well as holding medical affairs and commercial roles in biopharma and diagnostics.
More from appointments
Approximately 8 fully matching, plus 142 partially matching documents found.
Latest from PMHub
-
Should diversity in clinical trials be mandatory?
Josiane Chuisseu — Head of Sales, BioPharma of Source Bioscience. Ash Rishi – CEO and Co-Founder of COUCH Health and Demand Diversity.
-
New from the PhRMA: Diversity in clinical trials principles summarised
will be committed to tackling the issue, and include guidance for biopharma companies who choose to adopt these principles. ... 4.Enhancing information about diversity in clinical trial participation. Finally, PhRMA encourages biopharma companies who
-
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering
small and midsize biopharma clients. ... Two Labs, founded in 2003 and headquartered in Powell, Ohio, has offices and operations across the US and UK, and is an established strategic consulting and commercialization provider to the biopharma
-
August 2020: diversity and inclusion in clinical trials round-up
Improving diversity by starting within. Women of Color in Pharma (WOCIP) recently hosted a roundtable for 10 study sponsors and CROs about equality in biopharma.
-
Webinar: How to develop an optimal value story for your product
Expert panelists: . Marcus Dahlman, European Head of Market Access at Hansa Biopharma.
More from PMHub
Approximately 1 fully matching, plus 18 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- GSK launches late-stage testing of RSV vaccine candidate in older adults
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- Sinovac’s COVID-19 vaccine appears safe in older adults
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
